Back

Increase of beta-blocker dose and QT interval in heart failure - do we really know it all by heart? Results from CIBIS ELD study.

29 April 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Beta blockers Beta blockers HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Professor Svetlana Apostolovic

Clinical Center of Nis, Nis (Serbia)

5 More presentations in this session

Presentation thumbnail
Beneficial effects of beta-blockers and ivabradine combination in patients hospitalized due to worsening of heart failure: findings from
Professor Y. Lopatin (Volgograd, RU)
Abstract
Presentation thumbnail
Are beta-blockers effective in children with congestive heart failure? - A Cochrane review
Doctor S. Alabed (Sheffield, GB)
Abstract Slides
Presentation thumbnail
Quality of life is similar in patients with chronic stable heart failure on vasodilating and non-vasodilating beta blockers.
Doctor R. Pharithi (London, GB)
Presentation thumbnail
The impact of 12 month beta-blocker therapy on left and right ventricular volumes and ejection fraction and functional status of heart failure patients with midrange ejection fraction
Professor M. Poltavskaya (Moscow, RU)
Abstract
Presentation thumbnail
Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure
Doctor H. Froehlich (Heidelberg, DE)

Access the full session

Session thumbnail
Poster Session 2 - Beta blockers

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources